18 May – 21 May 2019 in MELBOURNE CONVENTION AND EXHIBITION CENTRE, MELBOURNE, VICTORIA, AUSTRALIA
Shiitake dermatitis after ‘detoxification’ diet
Isobornyl acrylate and the rising incidence of contact dermatitis to glucose sensors
Systemic treatment for vitiligo: Why, when and how?
Durability of response in plaque psoriasis patients receiving certolizumab pegol over 48 Weeks in phase 3 studies: CIMPASI-1, CIMPASI-2, CIMPACT
Efficacy of certolizumab pegol in psoriasis patients failing to respond to etanercept in an ongoing, phase 3, randomised controlled study
5 Adult cases of granular parakeratosis associated with enzalkonium chloride exposure through laundry rinse aid
Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma in an Australian Cohort.
Lichen aureus: A case report and histopathological presentation of a rare subtype of pigmented purpuric dermatoses
Mycosis fungoides masquerading as a pigmented purpuric dermatosis
Which came first, purpuric mycosis fungoides or pigmented purpuric dermatosis? A diagnostic dilemma
A case series of 13 patients with oestrogen hypersensitivity vulvitis treated with cyproterone acetate
Intradermal testing for autoimmune progesterone dermatitis – should we be basing our diagnosis on it?
Allergic contact dermatitis to alcohol swabs masquerading as a tape allergy
Improving skin health in the South Pacific – meeting the need
The U.K. skin cancer ‘two-week rule’ referral system: Audit to ascertain appropriate referrals at our institution
EASI-75 interpretation from a patient perspective – a phase 2b post-hoc analysis of dupilumab in adults with moderate-to-severe atopic dermatitis
2019 Dermcoll, 52ND ANNUAL SCIENTIFIC MEETING
2018 Dermcoll, 51ST ANNUAL SCIENTIFIC MEETING
